RENOVORX, INC. Increase (Decrease) in Accounts Receivable
RENOVORX, INC. (RNXT) reported Increase (Decrease) in Accounts Receivable of $126.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2025-11-13
- RENOVORX, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$194.00K.
- RENOVORX, INC. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $121.00K.
- RENOVORX, INC. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $199.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month |
|---|---|---|---|
| 2025-09-30 | -$194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$73.00K derived: sum of 2 quarters · filed 2025-11-13 | $126.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $320.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $199.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |